BSc (Hons) Genetics, University of Wales, Swansea. Chartered Patent Attorney, European Patent Attorney, Member of FICPI and AUTM.
Jane is an experienced life sciences patent attorney with considerable experience of coordinating patent strategies across the world including both patent prosecution and third party issues. Her main areas of interest include antibodies, nucleic acid technologies and chemistry-biotechnology hybrid technologies.
Jane provides commercially relevant advice tailored to the needs and commercial goals of each client, be they a University, SME or multinational corporation. Jane regularly advises her clients on all aspects of filing and prosecution strategy, as well as third party issues such as oppositions, third party observations and due diligence investigations. In particular, she has considerable experience planning worldwide patenting strategies and co-ordinating their implementation before numerous patent offices, as well as directly representing clients at the European Patent Office.
Jane has been involved in a number of due diligence projects relating to company and IP acquisitions (for both acquirer and acquiree).
Jane read Genetics at the University of Wales, Swansea, choosing to specialise in the areas of human disease genetics and gene therapy technologies. Jane was awarded the Genetics prize for the highest finals examination marks. Prior to realising that her career path lay in the patent profession, Jane spent two years studying medicine at Oxford University
Jane joined Potter Clarkson in 2001 and became a Partner in 2011. Jane has continued to work in the field of biotechnology and deals with subjects including recombinant technology, antibody therapies, drug screening assays and gene therapy technologies. She also handles patent applications in a number of biotechnology and chemistry cross-over areas, in particular combined chemical-biotechnology assays for biological sample assessment and the biological production of modified chemical compounds.
Jane has spoken at international conferences on various points of European law and practice and has authored a number of opinion and educational pieces on issues arising in UK and European law. Jane is also a founder member of the editorial panel of Life Sciences Intellectual Property Review magazine (LSIPR) and has been named as one of the 2017 WIPR Leaders.
Jane has also been heavily involved with the Biotechnology YES competition for many years.